[Pharma clinics. Medication of the month. Imiquimod (Aldara): an immunomodulator for the skin].
Imiquimod is the first drug of a new therapeutic class encompassing cutaneous immune response modifiers. This molecule induces the synthesis and release of macrophage-related cytokines. It boosts some local immune responses. These properties are used to treat cutaneous viral condylomas. Other prospective therapeutic goals are presently scrutinized.
Hermanns-Lê
T
T
Service de Dermatopathologie, Université de Liège.
Nikkels
A F
AF
Uhoda
I
I
Petit
L
L
Piérard
G E
GE
D000276:Adjuvants, Immunologic / Q000494:pharmacology* / Q000627:therapeutic use; D000634:Aminoquinolines / Q000494:pharmacology* / Q000627:therapeutic use; D016207:Cytokines / Q000378:metabolism*; D006801:Humans; D000077271:Imiquimod; D008264:Macrophages / Q000276:immunology; D012871:Skin Diseases / Q000188:drug therapy* / Q000276:immunology
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D016207:Cytokines; D000077271:Imiquimod
Pharma clinics. Le médicament du mois. L'imiquimod (Aldara): un immunomodulateur pour la peau.